Oman Medical Devices Market Report 2026: MOH Registration, Royal Hospital, and Vision 2040 Commercial Intelligence
BioNixus delivers Oman medical device market intelligence — MOH registration tracking, Royal Hospital Muscat procurement data, and primary clinical research across Oman's government and growing private hospital network.
Executive Summary
~$260M
Oman medical devices market 2026
~$350M
Forecast 2030
6.0%
CAGR 2026–2030
Oman's medical devices market offers a less competitive commercial environment than Saudi Arabia or UAE, with strong specialist loyalty to established suppliers and procurement cycles that reward long-term account relationships. MOH Central Medical Stores procurement creates a concentrated access target, while the growing private hospital sector — Aster Royal, Al Hayat, and Badr Al Samaa chains — is creating decentralized procurement opportunities.
See the GCC Medical Devices Market Report for the full regional context.
Oman Key Hospital Accounts
Royal Hospital Muscat
Flagship tertiary care center; cardiac surgery, neurology, oncology, transplantation — highest-value device account in Oman
Sultan Qaboos University Hospital
Academic medical center with specialist training programs; strong influence on national clinical protocols
Khoula Hospital
Orthopedics and trauma center; highest surgical instrument and orthopedic implant consumption in Oman
Al Nahdha Hospital
Major general hospital in Muscat serving large outpatient population; monitoring and diagnostics procurement
Aster Royal Hospital
Largest private hospital group in Oman; independent procurement with premium device tolerance
Badr Al Samaa Group
Multi-facility private healthcare group; growing specialty services driving device procurement outside MOH
Oman medical devices market — MOH procurement, Royal Hospital, and Vision 2040 FAQ
How big is the Oman medical devices market in 2026?
The Oman medical devices market is estimated at USD 240–280 million in 2026, growing at approximately 6% CAGR through 2030. MOH Oman procurement accounts for approximately 70% of total device spend, with private hospitals — including Aster Royal, Badr Al Samaa, and Al Hayat International — accounting for the remainder. Oman Vision 2040's healthcare privatization commitments are gradually expanding the private channel and creating new procurement pathways beyond MOH.
How does Oman medical device registration and procurement work?
The Ministry of Health Oman (MOH) oversees medical device registration through its Directorate General of Pharmaceutical Affairs. Oman accepts CE-marked and FDA-cleared devices with supporting technical documentation. Registration timelines typically range from 6–18 months. MOH procurement is centralized through the Central Medical Stores and hospital-level procurement committees. Royal Hospital (the flagship academic medical center) and Sultan Qaboos University Hospital are the two highest-priority accounts. BioNixus tracks MOH Oman registration and procurement cycles by device category.
What are the leading medical device segments in Oman?
Diagnostic imaging, cardiovascular devices, diabetes care equipment, and patient monitoring systems are Oman's leading medical device segments by value. Diabetes prevalence (~19% adult population) creates strong structural demand for glucose monitoring and insulin delivery devices. Cardiovascular disease and cancer are the two leading causes of mortality, driving demand for cardiac intervention devices and oncology-related diagnostic and therapeutic equipment.
How is Oman Vision 2040 affecting the medical devices market?
Oman Vision 2040's health pillar targets a 35% private sector healthcare share (vs. approximately 30% currently), expansion of health insurance coverage to expatriate residents, and development of integrated health cities. The Oman Health Information System (OHIS) digitalization is improving procurement data visibility. These structural shifts are expected to accelerate private hospital medical device procurement and create more competitive tender dynamics as private insurance coverage grows.
What is the Royal Hospital Oman's role in medical device procurement?
Royal Hospital Muscat is Oman's flagship tertiary care center and the country's highest-value medical device account. Royal Hospital operates specialist programs in cardiac surgery, neurology, oncology, and organ transplantation — creating disproportionate demand for high-acuity devices relative to its bed count. Key Account Management strategy in Oman typically prioritizes Royal Hospital and Sultan Qaboos University Hospital before other MOH facilities.
How does BioNixus approach Oman medical device and pharmaceutical research?
BioNixus covers Oman as part of GCC-wide market research programs. Primary HCP research engages specialists at Royal Hospital, Sultan Qaboos University Hospital, and major private facilities. Programs include quantitative physician surveys, procurement intelligence research, MOH registration tracking, and competitive landscape analysis. Oman-specific standalone programs are available, particularly for clients entering the GCC market with an Oman-first strategy due to lower competitive intensity versus Saudi Arabia or UAE.
Request the BioNixus Oman Medical Devices Intelligence Briefing
MOH Oman registration tracking, Royal Hospital and SQUH account intelligence, and primary HCP research across Oman's government and private hospitals.
Request a briefing